ArticleInternational journal of clinical and experimental pathology2026
A seven-gene panel with diagnostic and prognostic value for idiopathic pulmonary fibrosis and candidate herbal drugs identified based on these genes.
Article in International journal of clinical and experimental pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe objective of this study was to identify key idiopathic pulmonary fibrosis (IPF) related genes, thereby establishing a novel IPF diagnostic/warning panel and proposing drugs against IPF based on the strategy of targeting key genes.
methodsThe GEO datasets GSE245965, GSE279637, and GSE235435 were used to select IPF-related genes, as well as the IPF associated genes from the GeneCards and DisGeNET databases. The DEGs were used for enrichment analysis, PPI network construction, and targeted therapeutic value analysis.
resultsAn intersection analysis yielded 60 commonly up-regulated genes and 16 commonly down-regulated genes. GO/KEGG/Reactome/Immunologic Signature terms that were novel and interesting were found to be enriched. In the interaction network, WDR90 and ANKRD1 were identified as hub genes. Among the 60 common up-regulated genes, seven (namely SERPINB3, TUBB3, SERPINB4, CHTF18, BAX, WDR90 and ITGAX) were shared by the disease sets. In the Symmap database, we found some herbs with the most targets, such as Lygodii Spora, Smilacis Glabrae Rhizoma, and Aloe.
conclusionsA panel comprising seven key IPF genes was identified, which may have diagnostic and prognostic value for IPF. A comprehensive analysis of the Dgidb database revealed potential drugs that may be antitumor agents against IPF, such as Lygodii Spora, Smilacis Glabrae Rhizoma, and Aloe.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.